First Light Asset Management, LLC United Therapeutics Corp Transaction History

First Light Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $230,869 - $314,362	-1,121 Reduced 45.46%	1,345 $374,000
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $379,616 - $431,180	2,466 New	2,466 $412,000
Q3 2020 Nov 13, 2020	SELL	$99.9 - $121.13 $12.8 Million - $15.5 Million	-128,138 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $34,406 - $46,679	-371 Reduced 0.29%	128,138 $15.5 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $10.2 Million - $14.8 Million	128,509 New	128,509 $12.2 Million

692

60.6M

194K

298K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $15.8B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.